Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overdose Methamphetamine”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT06033365
What this trial is testing

Beginning Early and Assertive Treatment for Methamphetamine Use Disorder

Who this might be right for
Methamphetamine Use Disorder
Denver Health and Hospital Authority 192
Not applicableStudy completedNCT06076564
What this trial is testing

Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality

Who this might be right for
Stimulant OverdoseOverdose AccidentalOverdose Cocaine+1 more
San Francisco Department of Public Health 176
Not applicableLooking for participantsNCT06852170
What this trial is testing

Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention

Who this might be right for
Substance AbuseDecision Making, SharedImplementation Science+4 more
Chestnut Health Systems 341
Large-scale testing (Phase 3)Looking for participantsNCT06633900
What this trial is testing

Naltrexone for Overdose Prevention

Who this might be right for
Overdose Accidental
University of California, San Francisco 100
Testing effectiveness (Phase 2)Ended earlyNCT04715230
What this trial is testing

Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose

Who this might be right for
Methamphetamine Intoxication (Disorder)
InterveXion Therapeutics, LLC 20